Nestle Investor Event Presentation Deck

17 O Market share 15.8% 500 2021 sondolis HP2 kcal Oct '21 November 29, 2022 Boosting growth in the core Clinical evidence to drive differentiated market access and growth Mar '22 45.6% N Clinutren Thicken P W Reinbursement in homecare 2022 42% Jul '22 Market investment and execution drives growth Thicken-Up Clear ● First & only dysphagia product with reimbursement Sondalis 2.0 First hyper- concentrated tube feeding reimbursed in homecare C+ Locally produced products accelerate growth Nun resource energy 25.8% 2019 resource protein Nound resource diabet 25.6% N resource 20-fibre 2020 Nesne resource Junio NHSc Türkiye % market share 26.6% Ne resource Junio Fare 2021 SLAR 27.9% 9M 2022 Nestlé investor seminar 2022

View entire presentation